Skip links and keyboard navigation

Cancer Collaborative Biobank (CCB)

The Cancer Collaborative Biobank (CCB) stores human biological biospecimens (samples) obtained with consent from patients diagnosed with a haematologic malignancy, for use in research. The CCB is housed at the Princess Alexandra Hospital, Brisbane.

Purpose

The purpose of storing samples is to facilitate laboratory based research into haematologic malignancies.

The function of the CCB is to provide samples from patients with these diseases, for use in approved research projects – thereby facilitating a wide range of research activities.

The ultimate goal of facilitating such research is to improve our understanding of the processes leading to the development of haematologic malignancy, factors which govern the variable response to current treatments and ultimately the development of more effective therapies for patients suffering from haematologic malignancy.

Operations

The CCB operates within the Centres for Health Research and is overseen by the CCB Management Committee – made up of haematologists and interested professionals.  

The CCB operations have been reviewed and approved by the Metro South Health Human Research Ethics Committee.  All policies abide by the National Statement on the Ethical Conduct of Research Involving Humans from the NHMRC.

Funding

The CCB is funded by the Metro South Health Study, Education and Research Trust Account (SERTA) Committee until July 2018.

Patients and participants

Patients and participants

Information for patients and participants of the Cancer Collaborative Biobank.

Researchers

Researchers

Types of samples and data available and how to apply to the CCB.

Last updated 3 April 2017
Last reviewed 3 April 2017

Page feedback

Contact (optional)

Please provide your phone number or email address if you are happy for us to contact you with any follow-up questions.